MP Murphy

First name:
MP
Last name:
Murphy
Barone, E., Mancuso, C., Di Domenico, F., Sultana, R., Murphy, M. P., Head, E., & Butterfield, D. A. (2012). Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. Journal Of Neurochemistry, 120(1), 135-46. https://doi.org/10.1111/j.1471-4159.2011.07538.x
View
Duncan, M. J., Guerriero, L. E., Köhler, K., Beechem, L. E., Gillis, B. D., Salisbury, F., et al. (2022). Chronic Fragmentation of the Daily Sleep-Wake Rhythm Increases Amyloid-beta Levels and Neuroinflammation in the 3xTg-AD Mouse Model of Alzheimer's Disease. Neuroscience, 481, 111-122. https://doi.org/10.1016/j.neuroscience.2021.11.042 (Original work published 2022)
View
Malec, J. F., Salisbury, D. B., Anders, D., Dennis, L., Groff, A. R., Johnson, M., et al. (2021). Response to the COVID-19 Pandemic Among Posthospital Brain Injury Rehabilitation Providers. Archives Of Physical Medicine And Rehabilitation, 102(3), 549-555. https://doi.org/10.1016/j.apmr.2020.10.137
View
Weidner, A. M., Bradley, M. A., Beckett, T. L., Niedowicz, D. M., Dowling, A. L., Matveev, S. V., et al. RNA oxidation adducts 8-OHG and 8-OHA change with Aβ42 levels in late-stage Alzheimer's disease. Plos One, 6(9), e24930. https://doi.org/10.1371/journal.pone.0024930 (Original work published 2011)
View
Sompol, P., Furman, J. L., Pleiss, M. M., Kraner, S. D., Artiushin, I. A., Quintero, J. E., et al. (2017). Calcineurin/NFAT Signaling in Activated Astrocytes Drives Network Hyperexcitability in Aβ-Bearing Mice. The Journal Of Neuroscience : The Official Journal Of The Society For Neuroscience, 37(25), 6132-6148. https://doi.org/10.1523/JNEUROSCI.0877-17.2017 (Original work published 2017)
View
Bradley-Whitman, M. A., Timmons, M. D., Beckett, T. L., Murphy, M. P., Lynn, B. C., & Lovell, M. A. (2014). Nucleic acid oxidation: an early feature of Alzheimer's disease. Journal Of Neurochemistry, 128(2), 294-304. https://doi.org/10.1111/jnc.12444
View
Lovell, M. A., Lynn, B. C., Fister, S., Bradley-Whitman, M., Murphy, M. P., Beckett, T. L., & Norris, C. M. (2016). A Novel Small Molecule Modulator of Amyloid Pathology. Journal Of Alzheimer's Disease : Jad, 53(1), 273-87. https://doi.org/10.3233/JAD-151160 (Original work published 2016)
View
Lange, M. L. B., St Clair, D., Markesbery, W. R., Studzinski, C. M., Murphy, M. P., & Butterfield, D. A. (2010). Age-related loss of phospholipid asymmetry in APP(NLh)/APP(NLh) x PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice: relevance to Alzheimer disease. Neurobiology Of Disease, 38(1), 104-15. https://doi.org/10.1016/j.nbd.2010.01.004
View
Aluise, C. D., Robinson, R. A., Beckett, T. L., Murphy, M. P., Cai, J., Pierce, W. M., et al. (2010). Preclinical Alzheimer disease: brain oxidative stress, Abeta peptide and proteomics. Neurobiology Of Disease, 39(2), 221-8. https://doi.org/10.1016/j.nbd.2010.04.011
View
Butterfield, D. A., Barone, E., Di Domenico, F., Cenini, G., Sultana, R., Murphy, M. P., et al. (2012). Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain. The International Journal Of Neuropsychopharmacology, 15(7), 981-7. https://doi.org/10.1017/S1461145711001118
View